secwatch / observer

8-K filed December 12, 2022, 6:59 PM ET ticker INMB CIK 0001711754

other confidence high sentiment neutral materiality 0.25

INmune Bio extends shareholder rights plan to Dec 30, 2023 via Amendment No. 2

Inmune Bio, Inc.

Board adopted Amendment No. 2 to Rights Agreement on December 9, 2022.
Expiration date of the poison pill extended from Dec 30, 2022 to Dec 30, 2023.
Amendment entered with VStock Transfer, LLC as rights agent.
Prior amendment (Dec 2021) had extended the plan to Dec 30, 2022.

item 1.01 item 3.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Inmune Bio, Inc. amended Amendment No. 2 to Rights Agreement with VStock Transfer, LLC (effective 2022-12-09).

Action: amendment
Counterparty: VStock Transfer, LLC
Effective: 2022-12-09

Exact text from the filing

On December 9, 2022, the Company and VStock Transfer, LLC entered into Amendment No. 2 to Rights Agreement (“Amendment No. 2”).

View on SEC.gov

Browse all material agreements →

Inmune Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-079142

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.